Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants.
Iaconis D, Bordi L, Matusali G, Talarico C, Manelfi C, Cesta MC, Zippoli M, Caccuri F, Bugatti A, Zani A, Filippini F, Scorzolini L, Gobbi M, Beeg M, Piotti A, Montopoli M, Cocetta V, Bressan S, Bucci EM, Caruso A, Nicastri E, Allegretti M, Beccari AR.
Iaconis D, et al. Among authors: zippoli m.
Cell Death Dis. 2022 May 25;13(5):498. doi: 10.1038/s41419-022-04961-z.
Cell Death Dis. 2022.
PMID: 35614039
Free PMC article.